Mirus Bio™ TransIT™-BrCa Transfection Reagent

Description

Dedicated breast-cancer-cell-line-specific reagent. Delivers efficiently to many breast cancer cell types and maintains low cellular toxicity. Transfection with TransIT™-BrCa Reagent does not require medium changes and can be performed in serum-containing medium.

• Broad spectrum DNA delivery: Achieve high expression levels in breast cancer cell types including MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468 and T47D
• Formulated for low cellular toxicity: Maintain cell density and reduce experimental biases due to toxicity
• Multiple applications: Transient and stable transfections for gene expression, shRNA expression and promoter analyses

Specifications

• Cell Type: Cancer Cells
• Format: Tube
• Promoter: None (Promoterless)
• Transfection Technique: Chemical Transfection
• For Use With (Application): Achieve high expression levels in breast cancer cell types including MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468 and T47D, transient and stable transfections for gene expression, shRNA expression and promoter analyses
• Product Type: Transfection Reagent
• Quantity: 5 x 1 mL
• Sterility: Sterile